Literature DB >> 569471

Excretion of MHPG in normal subjects: implications for biological classification of affective disorders.

L E Hollister, K L Davis, J E Overall, T Anderson.   

Abstract

Exretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) was measured repeatedly in 17 normal subjects. The amount of MHPG excreted over a 24-hour period was fairly stable over a period of three consecutive 24-hour samplings, but stability was rather poor over subsequent periods of several weeks, suggesting that execretory patterns are not traits. A normal range of MHPG excretion was estimated to be 900 to 3,500 micrograms/24 hr. This range covers the majority of persons with affective disorders whose excretion patterns have been measured, although comparisons of absolute values between laboratories must be made cautiously. Further, substantial changes within this range may occur in normal subjects with no accompanying change in affect. A slight but definite diurnal pattern of excretion was found, with a peak at the period of 1600 to 1800 hours. No clear relationship to MHPG excretion to state of physical activity, recent consumption of foods or beverages, or prevailing affective state was defined in those subjects living under normal conditions. While MHPG excretion may yet prove useful for categorizing depressed patients and predicting response to drugs, any inferences drawn regarding the pathogenesis of affective disorders must be guarded.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 569471     DOI: 10.1001/archpsyc.1978.01770360014001

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  9 in total

1.  Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.

Authors:  B Scatton; H Loo; T Dennis; C Benkelfat; C Gay; M F Poirier-Littre
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  More effective use of antidepressants.

Authors:  L E Hollister
Journal:  West J Med       Date:  1979-08

3.  Lack of circadian rhythm in plasma levels of 3,4-dihydroxyphenylethyleneglycol in healthy human subjects.

Authors:  T Dennis; C Benkelfat; Y Touitou; A Auzeby; M F Poirier; B Scatton; H Lôo
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 4.  Amoxapine: a review of its pharmacology and efficacy in depressed states.

Authors:  S G Jue; G W Dawson; R N Brogden
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

Review 5.  Current antidepressant drugs: their clinical use.

Authors:  L E Hollister
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

6.  Sulfate and glucuronide conjugates of 3-methoxy-4-hydroxyphenylglycol (MHPG) in urine of depressed patients: central and peripheral influences.

Authors:  L Peyrin; J M Pequignot; G Chauplannaz; B Laurent; G Aimard
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

7.  Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depression.

Authors:  H Loo; C Benkelfat; J M Vanelle; T Dennis; M F Poirier; J P Olie; B Scatton
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

8.  Free and conjugated 3-methoxy-4-hydroxyphenylglycol in human urine: peripheral origin of glucuronide.

Authors:  L Peyrin; J M Pequignot
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 9.  Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.

Authors:  W Z Potter
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.